Catalyst biosciences inc

Major-Pharmaceuticals

CBIO


611 Gateway Boulevard
South San Francisco , CA 94080

Executive/
Director

Price

  • Last Close
  • $ 0.51
    $ -0.01 -2.67 %
    Oct 30, 2023
  • 52-Week High/Low
  • $0.56 - $0.34
  • YTD
  • 0%

  • Trading Volume
  • 483,723
  • Market Cap Full
  • $ 19.4M
  • Shares Outstanding
  • 38M
    Oct 20, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - -46.3% -3.3% 89.2% 2.8% -5% -18.3% -27.5% -60.8% -
Q2 - -9.5% -50.7% -50.6% -13.2% 4% -14.1% 169.7% 70.1% -
Q3 -47.5% -20.4% 8.8% -6.9% -31.2% 8% -5.3% -71.9% 36.9% -
Q4 -32.8% -46.3% 169% -25.1% 34.9% 35% -77.8% 5.6% 4.3% -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 -46.6% 5.3% -30.3% 2.4% 3.8% 60% 7.7% 47.8% -13.9% 6% - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%-79%40%-42%-13%-10%-85%-42%-3%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022
Q1 0.20 0.31 4.57 0.56 1.26 -0.28 -0.79 -0.46
Q2 0.10 0.42 2.53 0.54 1.15 -0.96 -0.64 1.64
Q3 - 0.40 1.34 0.64 1.06 -0.73 -0.8 -0.16
Q4 - 4.68 0.96 0.91 -1.13 -0.96 -0.64 -1.28
A 0.3 5.8 9.4 2.7 2.3 -2.9 -2.9 -0.3

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 12 12.1 31.3 31.5 37.8
Jun 11.9 12 17.4 31.3 31.5 37.8
Sep 11.9 12 22.1 31.4 31.5 38
Dec 11.9 12 22.1 31.4 31.5 38

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - 7 5.3 - -
Total Asset Turnover - 0.1 0.2 - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 9 - 57 28.5 8.5
Equity multiplier - - 0.1 - -